How new hepatitis C drugs could tackle liver cancer, too

How to cut rates of liver cancer? Reducing hepatitis C rates would be a good start. Wider availability of newer hepatitis C drugs may not only lead to fewer cases of this blood-borne disease, but may also slow the rise in related liver cancer. But these so-called direct acting antiviral drugs have not been widely available in Australia or overseas for long enough for us to confirm this long-term trend. So, we need to see if their increased use is li